You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

A chat with Val Romberg

Kedrion Biopharma's new CEO shares his views

read more 

EVENTS

Turkey, Kedrion supports the XVII International Congress on Hemophilia

The present and future role of Factor VIII at the center of the symposium supported by Kedrion

read more 

EVENTS

Kedrion is one of the main sponsors of the National SISET Conference

The company sponsors two scientific lectures, a testament to its close ties with the world of medicine and science

read more 
  1. EVENTS - 17-04-2020

    World Hemophilia Day: socially distant but still united with patients

    Now more than ever, Kedrion is renewing its commitment to those who live with this rare disorder

    read more 
  2. EVENTS - 16-04-2020

    Kedrion supports live streaming of medical debate on the use of convalescent plasma to treat Covid-19

    Online roundtable “The Gift of the Cured versus the Pandemic” on air at DonatoriH24 on April 16

    read more 
  3. CORPORATE - 07-04-2020

    Coronavirus, from Plasma an anti Covid-19 treatment

    Kedrion’s commitment to find a treatment from convalescent patient plasma

    read more 

Pages

For more information please contact: pressoffice@kedrion.com